CTMX(CytomX Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-06-15 | Ogden Christopher | Chief Financial Officer | 公开市场卖出 | 1,624 | $3.05 |
| 2026-03-17 | Chu Yu-Waye | Chief Medical Officer | 公开市场卖出 | 21,279 | $6.42 |
| 2026-03-17 | McCarthy Sean A. | CEO | 公开市场卖出 | 118,969 | $6.42 |
| 2026-03-17 | BELVIN MARCIA | SVP, Chief Scientific Officer | 公开市场卖出 | 31,492 | $6.42 |
| 2026-03-17 | Ogden Christopher | Chief Financial Officer | 公开市场卖出 | 19,323 | $6.42 |
| 2025-11-06 | McCarthy Sean A. | CEO | 公开市场卖出 | 101,793 | $4.54 |
| 2025-06-16 | Ogden Christopher | Chief Financial Officer | 公开市场卖出 | 10,614 | $2.69 |
| 2025-06-16 | BELVIN MARCIA | SVP, Chief Scientific Officer | 公开市场卖出 | 13,884 | $2.69 |
| 2025-06-16 | McCarthy Sean A. | CEO | 公开市场卖出 | 55,511 | $2.69 |
| 2025-06-13 | Ogden Christopher | Chief Financial Officer | 公开市场卖出 | 1,641 | $2.95 |
| 2025-03-18 | McCarthy Sean A. | CEO | 公开市场卖出 | 37,656 | $0.60 |
| 2025-03-18 | Ogden Christopher | Chief Financial Officer | 公开市场卖出 | 8,551 | $0.60 |
| 2025-03-18 | Chu Yu-Waye | Chief Medical Officer | 公开市场卖出 | 4,025 | $0.60 |
| 2025-03-18 | ROWLAND LLOYD A | General Counsel | 公开市场卖出 | 10,203 | $0.60 |
| 2025-03-18 | BELVIN MARCIA | SVP, Chief Scientific Officer | 公开市场卖出 | 19,512 | $0.60 |